dc.contributor.author | Hay, Elizabeth Anne | |
dc.contributor.author | Khalaf, Abdulla Razak | |
dc.contributor.author | Marini, Pietro | |
dc.contributor.author | Brown, Andrew | |
dc.contributor.author | Heath, Karyn | |
dc.contributor.author | Sheppard, Darrin | |
dc.contributor.author | MacKenzie, Alasdair | |
dc.date.accessioned | 2016-11-30T13:28:20Z | |
dc.date.available | 2016-11-30T13:28:20Z | |
dc.date.issued | 2017-08 | |
dc.identifier.citation | Hay , E A , Khalaf , A R , Marini , P , Brown , A , Heath , K , Sheppard , D & MacKenzie , A 2017 , ' An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome ' , Neuropeptides , vol. 64 , pp. 101-107 . https://doi.org/10.1016/j.npep.2016.11.003 | en |
dc.identifier.issn | 0143-4179 | |
dc.identifier.other | PURE: 73235151 | |
dc.identifier.other | PURE UUID: f19aae0c-77ab-493e-b412-deff773220aa | |
dc.identifier.other | PubMed: 27866656 | |
dc.identifier.other | Scopus: 85006804245 | |
dc.identifier.other | ORCID: /0000-0002-8456-4473/work/29354671 | |
dc.identifier.uri | http://hdl.handle.net/2164/7773 | |
dc.description | Acknowledgements These studies were funded by a Wellcome Trust (105625/Z/14/Z) ISSF starting grant, Medical Research Scotland (PhD-719-2013) and GW Pharmaceuticals (PhD-719-2013 - S.5242.001). | en |
dc.format.extent | 7 | |
dc.language.iso | eng | |
dc.relation.ispartof | Neuropeptides | en |
dc.rights | © 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) | en |
dc.subject | neuropeptide | en |
dc.subject | enhancer | en |
dc.subject | CAS9/CRISPR | en |
dc.subject | Off-target effects | en |
dc.subject | transgenic mouse | en |
dc.subject | CAS9 mRNA | en |
dc.subject | gRNA | en |
dc.subject | 1-cell mouse embryo | en |
dc.subject | Cytoplasmic microinjection | en |
dc.subject | CRISPR design tool | en |
dc.subject | UCSC browser BLAT | en |
dc.subject | PCR | en |
dc.subject | Sanger sequencing | en |
dc.subject | R Medicine | en |
dc.subject | Wellcome Trust | en |
dc.subject | 105625/Z/14/Z | en |
dc.subject.lcc | R | en |
dc.title | An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Education | en |
dc.contributor.institution | University of Aberdeen.Biological Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1016/j.npep.2016.11.003 | |
dc.identifier.vol | 64 | en |